Elanco Animal Health Inc. ELAN Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $785M+14.8% | $589M+13.5% | $607M+12.8% | $713M+3.5% | $684M-0.9% | ||
| $57M+42.5% | $80M+73.9% | $52M-10.3% | $48M-26.2% | $40M-39.4% | ||
| $57M-14.9% | -$276M— | -$34M-109% | $11M+122% | $67M+109% | ||
| $316M+21.1% | -$5M— | $178M-77.4% | $242M+24.1% | $261M+7.0% | ||
| $144M+44.0% | -$179M— | $2M-99.7% | $73M+121% | $100M+28.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elanco Animal Health Inc.'s revenue?
- Elanco Animal Health Inc. (ELAN) generated $4.9B in revenue over the trailing twelve months, up 10.5% year over year.
- Is Elanco Animal Health Inc. profitable?
- Elanco Animal Health Inc. is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months, a -4.9% net margin.
- What is Elanco Animal Health Inc.'s earnings per share?
- Elanco Animal Health Inc.'s diluted EPS over the trailing twelve months is $-0.50.
- Where does Elanco Animal Health Inc.'s income statement data come from?
- Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
